Frédéric Blanc
Frédéric Blanc, MD, PhD is an expert in Neurology at Hôpitaux Universitaires de Strasbourg (France). As of October 2026, ScienceLeadR ranks Frédéric Blanc in the top 1% of experts worldwide for Dementia, Neurocognitive Disorders and Alzheimer Disease. Frédéric Blanc has authored 358 publications, the most recent in 2026, and is an investigator in 22 clinical trials, 5 of them ongoing. SLR score: 1,507 (community average: 125). How the SLR is computed.
LeadR Profile
Neurology
Subspecialties: Psychiatry - Geriatrics - Psychology
Main Topics
Publications and Clinical Studies
Profile data updated on
Expert Rankings
Top experts on the MeSH terms this expert works on
Short Biography
- Current research interests:
- Biomarkers of dementia with Lewy bodies and Alzheimer's disease using brain MRI, PET, CSF and blood, particularly at the early stages (SCI, MBI, MCI, mild dementia)
- Neural basis of cognition and behaviour in dementia with Lewy bodies and Alzheimer's disease, using brain MRI
- Clinical trials on dementia with Lewy bodies and Alzheimer's disease
Organizations
Career arc: 1993 - 2026
Number : 358
Citations
Main journals
Best Journals
Breakdown by type
Click a legend label to hide or show it in the chart.
Latest Publications
5 most recent indexed articles
Source: Pubmed
| Title | Journal | Year | Citations |
|---|---|---|---|
| The impact of long-term antiseizure treatment on cognitive decline in late-onset epileptic prodromal Alzheimer's disease: an exploratory study. PMID 42564239 — epilepsy, dementia, alzheimer disease, cognitive dysfunction, therapeutics, cognition | Front Aging Neurosci | 2026 | 0 |
| Cerebrospinal fluid α-synuclein and Aβ42 link with default mode and salience networks connectivity in dementia with Lewy bodies. PMID 42473545 — dementia, lewy bodies, brain, biomarkers, signs and symptoms, default mode network, synucleins | Alzheimers Dement (N Y) | 2026 | 0 |
| Beyond amyloid and tau: synaptic and neurodegenerative biomarkers shape MCI progression. PMID 42337011 — dementia, molecular biology, 14-3-3 proteins, mental disorders, cognitive dysfunction, biomarkers, neurosciences, amyloid, pentraxins | Mol Psychiatry | 2026 | 0 |
| Language and communication disorders in dementia with Lewy bodies versus Alzheimer's disease: Objective screening and subjective perspectives of patients, their caregivers and clinicians. PMID 42300742 — communication disorders, language, dementia, lewy bodies, alzheimer disease, neuropsychological tests, caregivers, communication, writing, language disorders, surveys and questionnaires | J Alzheimers Dis | 2026 | 0 |
| Regional gene expression and brain atrophy in dementia with Lewy bodies: an imaging transcriptomics study. PMID 41991538 — research design, genes, dementia, lewy bodies, atrophy, brain, gene expression | NPJ Parkinsons Dis | 2026 | 0 |
Clinical Studies 22
Synthesis
By phase:
By status:
By type:
By Monocentric/Multicentric:
Cohort/Consortium Investigators 10
Ongoing Clinical Trials
5 ongoing trials started since 2021, where this expert is an investigator
Source: ClinicalTrials
| Study | Phase | Status | Start |
|---|---|---|---|
| A study to evaluate the safety and long term biomarker effects of RO7269162 in participants at risk for or at the prodromal stage of Alzheimer s Disease (AD) 2023-506183-13-00 — administration, oral, safety, alzheimer disease, biomarkers, therapeutics, amyloid | Phase 2 | Active not recruiting | 2024 |
| Evaluating How Red light Therapy Applied to the Head Affects Symptoms Daily Life and Brain Activity in People With Dementia With Lewy Bodies NCT07602296 — skin, quality of life, dementia, lewy bodies, safety, brain, lewy body disease, signs and symptoms, phototherapy, diagnosis, house calls, enzyme multiplied immunoassay technique, therapeutics, lighting, environment, memory, sunlight, cognition, temperature, medical devices, head, bone and bones | N/A | Not yet recruiting | 2026 |
| Personalized Repetitive Transcranial Magnetic Stimulation (rTMS) in Cognitive Fluctuations of Dementia With Lewy Bodies (DLB) Proof of Concept NCT05138588 — dementia, lewy bodies, transcranial magnetic stimulation, arousal, diagnosis, pulse | N/A | Recruiting | 2022 |
| Cerebral and Cognitive Impact of Professional Soccer Practice NCT04903015 — white matter, neuropsychology, gray matter, craniocerebral trauma, brain damage, chronic, brain, soccer, iron overload, brain diseases, wounds and injuries, anatomy, retirement, quantitative susceptibility mapping | N/A | Recruiting | 2022 |
| Comparison of Therapeutic Strategies With Cholinesterase Inhibitors (SOS TRIAL) NCT03454646 — cholinesterase inhibitors, donepezil, dementia, alzheimer disease, pharmaceutical preparations, rivastigmine, galantamine, therapeutics, mental status and dementia tests, random allocation, cholinesterases, non-responder | Phase 4 | Not yet recruiting | 2024 |
LeadR Networks
Main global connection map